Skip to main content

Advertisement

SpringerLink
Log in

The EBV-DNA Can be Used as a Diagnostic and Follow-up Parameter of the Rhinopharyngeal Tumors in the Non-Endemic Population of the Western Sicily

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

To evaluate whether EBV-DNA can be used as a diagnostic and follow-up parameter for nasopharyngeal tumors in a non-endemic population. The study was carried out in a university hospital. A retrospective study was conducted on 40 paraffin samples of histological preparations. EB-DNA was detected by real-time PCR technique. A prospective study was also conducted on a group of 30 patients who underwent nasopharyngeal biopsy for suspected nasopharyngeal carcinoma (NPC) by comparing EBV-DNA concentrations between the histological specimen and the serum. Quantification of genomic copies of EBV-DNA in serum and detection of anti-EBV antibodies was performed. In both groups the presence of high viral load of EBV-DNA was found in nonkeratinizing squamous cell carcinomas, in three cases of lymphepitomyoma and in 4 out of 6 cases of non-differentiated non-carcinoma lymph node metastases. squamous keratinizing cells. In all cases of NPC, an antibody pattern typical of reactivations (IgGVCA+, IgG-EA+, IgG-EBNA+) and IgA-EA-D, frequently positive in cases of NPC, has been highlighted. A good correlation between the high EBV-DNA charges and the histological diagnosis was highlighted. Our study also found that the assessment of viral EBV load can also be considered in the prognostic evaluation and in the follow-up of patients with NPC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cabibi D, Speciale R, Lorusso F (2013) Recurrent ossifying fibroma of the maxillary sinus in an adult patient. Pathologica 105(1):11–14

    CAS  PubMed  Google Scholar 

  2. Lo Casto A, Lorusso F, Lombardo F, Speciale R (2014) Secondary septal mucocele diagnosed by MRI and CBCT and treated surgically. B-ENT 10:221–225

    CAS  PubMed  Google Scholar 

  3. Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W et al (2002) Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer 97(4):489–492

    Article  CAS  PubMed  Google Scholar 

  4. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–768

    Article  CAS  PubMed  Google Scholar 

  5. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N (1992) Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 23:271–280

    Article  CAS  PubMed  Google Scholar 

  6. Chan KC, Lo YM (2002) Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol 12:489–496

    Article  CAS  PubMed  Google Scholar 

  7. Lung ML, Chang GC (1992) Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians. Int J Cancer 52(1):34–37

    Article  CAS  PubMed  Google Scholar 

  8. Busson P, Keryer C, Ooka T, Corbex M (2004) EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 12:356–360

    Article  CAS  PubMed  Google Scholar 

  9. Feng BJ, Huang W, Shugart YY et al (2002) Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31:395–399

    Article  CAS  PubMed  Google Scholar 

  10. Fasciana T, Capra G, Calà C, Zambuto S, Mascarella C, Colomba C, Di Carlo P, Giammanco A (2017) Helicobacter pylori and Epstein-Barr co-infection in gastric disease. Pharmacol Online Open Access Spec Issue 1:73–82

    Google Scholar 

  11. Giardina A, Rizzo A, Ferrante A, Capra G, Triolo G, Ciccia F (2013) Giant cell arteritis associated with chronic active Epstein-Barr virus infection (Article) Reumatismo Open. Access 1:36–39

    Google Scholar 

  12. Di Carlo P, Trizzino M, Titone L, Capra G, Colletti P, Mazzola G, Pistoia D, Sarno C (2011) Unusual MRI findings in an immunocompetent patient with EBV encephalitis: a case report. BMC Med Imaging 11:6. https://doi.org/10.1186/1471-2342-11-6

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vokes EE, Liebowitz DN, Weichselbaum RR (1997) Nasopharyngeal carcinoma. Lancet 350:1087–1091

    Article  CAS  PubMed  Google Scholar 

  14. McDermott AL, Dutt SN, Watkinson JC (2001) The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol 26:82–92

    Article  CAS  PubMed  Google Scholar 

  15. Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1:75–82

    Article  CAS  PubMed  Google Scholar 

  16. Hsu JL, Glaser SL (2000) Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34(1):27–53

    Article  CAS  PubMed  Google Scholar 

  17. de-Thé G, Day NE, Geser A et al (1975) Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study–a review. IARC Sci Publ. 11(2):3–16

    Google Scholar 

  18. Tierney RJ, Steven N, Young LS, Rickinson AB (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374–7385

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337

    Article  CAS  PubMed  Google Scholar 

  20. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594–599

    Article  CAS  PubMed  Google Scholar 

  21. Tugizov SM, Berline JW, Palefsky JM (2003) Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9:307–314

    Article  CAS  PubMed  Google Scholar 

  22. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ (2006) Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103:7065–7070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dowd JB, Palermo T, Brite J et al (2013) Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6–19, 2003–2010. PLoS ONE 8(5):e64921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Murphy G, Pfeiffer R, Camargo MC et al (2009) Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137(3):824–833

    Article  PubMed  Google Scholar 

  25. Stevens SJC, Verkuijlen SAWM, Hariwiyanto B, Harijadi, Fachiroh J, Paramita D, Tan IB, Haryana SM, Middeldorp JM (2005) Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 43:3066–3073

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM (2003) Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 63:2028–2032

    CAS  PubMed  Google Scholar 

  27. Mutirangura A, Pornthanakanem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S et al (1998) Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 4:665–669

    CAS  PubMed  Google Scholar 

  28. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877–1882

    Article  CAS  PubMed  Google Scholar 

  29. Bejarano MT, Masucci MG (1998) Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses. Blood 92(11):4256–4262

    Article  CAS  PubMed  Google Scholar 

  30. Feng P, Chan SH, Soo MY, Liu D, Guan M, Ren EC, Hu H (2001) Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis. Cancer. 92(7):1872–1880

    Article  CAS  PubMed  Google Scholar 

  31. Lo YM, Leung SF, Chan LY, Lo KW, Zhang J, Chan AT et al (2000) Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann N Y Acad Sci 906:99–101

    Article  CAS  PubMed  Google Scholar 

  32. Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ et al (2008) Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncol 44(8):784–792

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Otolaringology, Department of Experimental Biomedicine and Clinical Neurosciences, Polyclinic University Hospital “Paolo Giaccone”, University of Palermo, Via del Vespro, 133, 90127, Palermo, Italy

    F. Lorusso, S. Gallina, R. Speciale & F. Dispenza

  2. Department of Sciences for Health Promotion and Mother–Child Care “G. D’Alessandro”, Polyclinic University Hospital “Paolo Giaccone”, University of Palermo, Via del Vespro, 133, 90127, Palermo, Italy

    M. P. Caleca, C. Bellavia, T. Fasciana & G. Capra

  3. Polyclinic University Hospital “Paolo Giaccone”, Via del Vespro, 133, 90127, Palermo, Italy

    D. Pistoia

Authors
  1. F. Lorusso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. P. Caleca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Bellavia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Pistoia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Gallina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Speciale
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Dispenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Fasciana
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Capra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Capra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lorusso, F., Caleca, M.P., Bellavia, C. et al. The EBV-DNA Can be Used as a Diagnostic and Follow-up Parameter of the Rhinopharyngeal Tumors in the Non-Endemic Population of the Western Sicily. Indian J Otolaryngol Head Neck Surg 71, 396–400 (2019). https://doi.org/10.1007/s12070-018-1427-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-018-1427-z

Keywords

Search

Navigation